National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 2) (PB 15 of 2018) (Cth)
PB 15 of 2018
National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 2)
National Health Act 1953
I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 26 February 2018
LISA LA RANCE
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
Name of Instrument
(1)This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 2)
(2)This Instrument may also be cited as PB 15 of 2018.
Commencement
This Instrument commences on 1 March 2018.
Amendment of National Health (Pharmaceutical benefits—early supply) Instrument 2015
Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).
Schedule 1 Amendments
Schedule 1
omit:
| Risedronic acid and calcium | Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate) | 20 | 1 | 5 |
0
0
0